Adenosine deaminase activity in cerebrospinal fluid of HIV-infected patients: limited value for diagnosis of tuberculous meningitis

  • I. Corral
  • C. Quereda
  • E. Navas
  • P. Martín-Dávila
  • M.-J. Pérez-Elías
  • J.-L. Casado
  • V. Pintado
  • J. Cobo
  • E. Pallarés
  • J. Rubí
  • S. Moreno
Article

Abstract

Adenosine deaminase activity (ADA) determination in cerebrospinal fluid (CSF) is considered a specific test for the diagnosis of tuberculous meningitis. In order to study the variability of this marker in patients with different neurological disorders associated with HIV infection, and its utility for the diagnosis of tuberculous meningitis in these patients, the ADA levels in 417 CSF samples from HIV-infected patients with neurological symptoms were reviewed. HIV infection, HIV-associated neurological disorders, and progressive multifocal leukoencephalopathy were not associated with elevated ADA in CSF. Among patients with meningitis, receiver operating characteristic curve analysis gave an optimal ADA cut-off point of 8.5 IU/l for the diagnosis of tuberculous meningitis, with 57% sensitivity, 87% specificity, and an area under the curve of 0.747 (similar to that for CSF glucose concentration). False-positive results were found in patients with neurological CMV disease and cryptococcal, lymphomatous, and probable candidal meningitis. The results of this study indicate that ADA determination in CSF has limited utility for the diagnosis of tuberculous meningitis in HIV-infected patients.

References

  1. 1.
    Berenguer J, Moreno S, Laguna F, Vicente T, Adrados M, Ortega A, González-Lahoz J, Bouza E (1992) Tuberculous meningitis in patients infected with the human immunodeficiency virus. N Engl J Med 326:668–672PubMedGoogle Scholar
  2. 2.
    Sánchez-Portocarrrero J, Pérez-Cecilia E, Jiménez-Escrig A, Martín-Rabadán P, Roca V, Ruíz-Yagüe M, Romero-Vivas J, Palau E, Picazo JJ (1996) Tuberculous meningitis. Clinical characteristics and comparison with cryptococcal meningitis in patients with human immunodeficiency virus infection. Arch Neurol 53:671–676PubMedGoogle Scholar
  3. 3.
    López-Cortés LF, Cruz-Ruiz M, Gómez-Mateos J, Jiménez-Hernández D, Jiménez-Mejías E, Pachón J, Castillo J (1995) Adenosine deaminase activity in the CSF of patients with aseptic meningitis: utility in the diagnosis of tuberculous meningitis and neurobrucellosis. Clin Infect Dis 20:525–530PubMedGoogle Scholar
  4. 4.
    Casado JL, Quereda C, Oliva J, Navas E, Moreno A, Pintado V, Cobo J, Corral I (1997) Candidal meningitis in HIV-infected patients: analysis of 14 cases. Clin Infect Dis 25:673–676PubMedGoogle Scholar
  5. 5.
    John MA, Coovadia YM (2001) Shortfalls in the use of adenosine deaminase in tuberculous meningitis. Trop Doct 31:138–139PubMedGoogle Scholar
  6. 6.
    Martínez E, Domingo P, Ris J, Sambeat MA, Cadafalch J (1992) Cerebrospinal fluid adenosine deaminase levels in a patient with cryptococcal meningitis. Clin Infect Dis 15:1061–1062PubMedGoogle Scholar
  7. 7.
    Pedro-Botet J, Soriano JC, Miralles R, Rubiés-Prat J (1991) Adenosine deaminase in cerebrospinal fluid of cerebral toxoplasmosis in AIDS. Infection 19:13PubMedGoogle Scholar
  8. 8.
    Quereda C, Corral I, Laguna F, Valencia ME, Tenorio A, Echeverría JM, Navas E, Martín-Dávila P, Moreno A, Moreno V, González-Lahoz JM, Arribas JR, Guerrero A (2000) Diagnostic utility of a multiplex herpesvirus PCR assay performed with cerebrospinal fluid from human immunodeficiency virus-infected patients with neurological disorders. J Clin Microbiol 38:3061–3067PubMedGoogle Scholar
  9. 9.
    Tenorio A, Echevarria JE, Casas I, Echevarria JM, Tabares E (1993) Detection and typing of human herpesviruses by multiplex polymerase chain reaction. J Virol Methods 44:261–269CrossRefPubMedGoogle Scholar
  10. 10.
    Fedele CG, Ciardi M, Delia S, Echevarria JM, Tenorio A (1999) Multiplex polymerase chain reaction for the simultaneous detection and typing of polyomavirus JC, BK and SV40 DNA in clinical samples. J Virol Methods 82:137–144CrossRefPubMedGoogle Scholar
  11. 11.
    Blake J, Berman P (1982) The use of adenosine deaminase assays in the diagnosis of tuberculosis. S Afr Med J 62:19–21PubMedGoogle Scholar
  12. 12.
    Sloats EH, Asberg EG, Van Keipema AR, Kruijswijk H (1985) A continuous method for the estimation of adenosine deaminase catalytic concentration in pleural effusions with a Hitachi 705 discrete analyser. J Clin Chem Clin Biochem 23:677–682PubMedGoogle Scholar
  13. 13.
    Working Group of the American Academy of Neurology AIDS Task Force (1991) Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1(HIV-1) infection. Neurology 41:778–785PubMedGoogle Scholar
  14. 14.
    Cantor SB, Sun CC, Tortolero-Luna G, Richards-Kortum R, Follen M (1999) A comparison of C/B ratios from studies using receiver operating characteristic curve analysis. J Clin Epidemiol 52:885–892CrossRefPubMedGoogle Scholar
  15. 15.
    Hanley JA, McNeil BJ (1983) A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148:839–843PubMedGoogle Scholar
  16. 16.
    Corral I, Quereda C, Martín-Dávila P, Gómez-Mampaso E, Fortún J, Muñoz V, Guerrero A (1998) Mycobacterium tuberculosis infection of the central nervous system: an 18 year experience. In: Casal M (ed) Clinical mycobacteriology. Prous Science, Barcelona, pp 357–361Google Scholar
  17. 17.
    Piras MA, Gakis C (1973) Cerebrospinal fluid adenosine deaminase activity in tuberculous meningitis. Enzyme 14:311–317Google Scholar
  18. 18.
    Ribera E, Martínez-Vázquez JM, Ocaña I, Segura RM, Pascual C (1987) Activity of adenosine deaminase in cerebrospinal fluid for the diagnosis and follow-up of tuberculous meningitis in adults. J Infect Dis 155:603–607PubMedGoogle Scholar
  19. 19.
    Machado LDR, Livramento JA, Spina-França A (1995) Adenosine deaminase in the cerebrospinal fluid of patients with the acquired immunodeficiency syndrome. Arq Neuropsiquiatr 53:755–759PubMedGoogle Scholar
  20. 20.
    Tortosa A, Rubio F, Reñé R, Peres J (1993) Infiltración progresiva de pares craneales como primera manifestación de un linfoma meníngeo primario. Med Clin 100:137–139Google Scholar
  21. 21.
    Corral I, Quereda C, Casado JL, Cobo J, Navas E, Pérez-Elías MJ, Pintado V, Guerrero A (1997) Acute polyradiculopathies in HIV-infected patients. J Neurol 244:499–504CrossRefPubMedGoogle Scholar
  22. 22.
    Arribas JR, Storch GA, Clifford DB, Tselis AC (1996) Cytomegalovirus encephalitis. Ann Intern Med 125:577–587PubMedGoogle Scholar
  23. 23.
    Donald PR, Malan C, Schoeman JF (1987) Adenosine deaminase activity as a diagnostic aid in tuberculous meningitis. J Infect Dis 156:1040–1041PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • I. Corral
    • 1
  • C. Quereda
    • 2
  • E. Navas
    • 2
  • P. Martín-Dávila
    • 2
  • M.-J. Pérez-Elías
    • 2
  • J.-L. Casado
    • 2
  • V. Pintado
    • 2
  • J. Cobo
    • 2
  • E. Pallarés
    • 3
  • J. Rubí
    • 3
  • S. Moreno
    • 2
  1. 1.Neurology ServiceHospital Ramón y CajalMadridSpain
  2. 2.Infectious Diseases ServiceHospital Ramón y CajalMadridSpain
  3. 3.Clinical Biochemistry ServiceHospital Ramón y CajalMadridSpain

Personalised recommendations